Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C HANSCH

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Cancer Chemotherapy Reports. Part 3|May 1, 1972
Structure-activity relationships: strategy in drug designC Hansch
Il Farmaco; Edizione Scientifica|January 1, 1979
QSAR in cancer chemotherapyC Hansch
The Journal of Organic Chemistry|March 1, 1970
Steric parameters in structure-activity correlations. Cholinesterase inhibitorsC Hansch
Il Farmaco; Edizione Scientifica|August 1, 1979
The interaction of ligands with enzymes. A starting point in drug designC Hansch
Journal of Chemical Education|June 1, 1974
Drug research or the luck of the drawC Hansch
Journal of Medicinal Chemistry|January 1, 1976
Correlation analysis of Baker's studies on enzyme inhibition. 1. Guanine deaminase, xanthine oxidase, dihydrofolate reductase, and complementC Silipo, C Hansch
Journal of Medicinal Chemistry|November 1, 1974
Structure-activity relationships in immunochemistry. 2. Inhibition of complement by benzamidinesC Hansch, M Yoshimoto
Journal of Medicinal Chemistry|September 1, 1970
Role of the benzyl moiety in biochemical and pharmacological processesC Hansch, R Kerley
Drug Metabolism Reviews|January 1, 1993
Quantitative structure-activity relationships of cytochrome P-450C Hansch, L Zhang
The Journal of Pharmacy and Pharmacology|August 1, 1990
The relative dependence of calcium antagonists and neuroleptics binding to brain and heart receptors on drug lipophilicityW Rojratanakiat, C Hansch
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy Reports. Part 3|May 1, 1972
Structure-activity relationships: strategy in drug designC Hansch
Il Farmaco; Edizione Scientifica|January 1, 1979
QSAR in cancer chemotherapyC Hansch
The Journal of Organic Chemistry|March 1, 1970
Steric parameters in structure-activity correlations. Cholinesterase inhibitorsC Hansch
Il Farmaco; Edizione Scientifica|August 1, 1979
The interaction of ligands with enzymes. A starting point in drug designC Hansch
Journal of Chemical Education|June 1, 1974
Drug research or the luck of the drawC Hansch
Journal of Medicinal Chemistry|January 1, 1976
Correlation analysis of Baker's studies on enzyme inhibition. 1. Guanine deaminase, xanthine oxidase, dihydrofolate reductase, and complementC Silipo, C Hansch
Journal of Medicinal Chemistry|November 1, 1974
Structure-activity relationships in immunochemistry. 2. Inhibition of complement by benzamidinesC Hansch, M Yoshimoto
Journal of Medicinal Chemistry|September 1, 1970
Role of the benzyl moiety in biochemical and pharmacological processesC Hansch, R Kerley
Drug Metabolism Reviews|January 1, 1993
Quantitative structure-activity relationships of cytochrome P-450C Hansch, L Zhang
The Journal of Pharmacy and Pharmacology|August 1, 1990
The relative dependence of calcium antagonists and neuroleptics binding to brain and heart receptors on drug lipophilicityW Rojratanakiat, C Hansch
Pageof 20